Wirya Ahmed Tofiq (1), Israa Hashim Saadoon (2)
Background (General): Human adenoviruses are widespread pathogens responsible for a significant proportion of respiratory tract infections, with genotype 7 (HAdV-7) associated with severe outcomes. Background (Specific): Despite its clinical importance, limited data exist regarding the prevalence and immunological impact of HAdV-7 among adult patients in Iraq. Knowledge Gap: The relationship between HAdV-7 infection and interleukin-6 (IL-6) levels in adults with respiratory illness has not been well characterized. Aim: This study aimed to detect HAdV-7 in adult patients with respiratory infections using RT-PCR and to evaluate its association with IL-6 levels. Results: Among 100 patients and 50 healthy controls, HAdV-7 was detected in 7% of cases, with no significant association with age, sex, or residence. Patients infected with HAdV-7 exhibited significantly elevated IL-6 levels (101.75 ± 25.17 pg/mL) compared with controls (39.26 ± 11.09 pg/mL, p ≤ 0.05). Novelty: This is one of the first molecular investigations in Iraq to link HAdV-7 infection with heightened IL-6 responses, highlighting the virus’s role in driving inflammatory pathways. Implications: Monitoring IL-6 levels may serve as a biomarker for disease severity in HAdV-7 infections and support timely therapeutic interventions to reduce complications.Highlight :
HAdV-7 detection by RT-PCR shows its link with increased IL-6 levels.
Molecular methods enhance sensitivity for early diagnosis.
IL-6 monitoring can guide prognosis and therapy.
Keywords : ELISA, RT-PCR, HAdV, Respiratory Infection, IL-6
T. Wreghitt and G. Kudesia, Clinical and Diagnostic Virology, 2nd ed. Cambridge, UK: Cambridge University Press, 2024, pp. 7–11.
Z. A. Muslim, “IL-6 (rs1800797) Variant as an Immunomarker for Children's Adenovirus Respiratory Infection: A Prospective Insight,” SAR J. Pathol. Microbiol., vol. 5, no. 6, pp. 198–201, 2024.
R. Allard and A. Vantarakis, “Adenoviruses,” in Water and Sanitation for the 21st Century: Health and Microbiological Aspects of Excreta and Wastewater Management (Global Water Pathogen Project), K. Edberg, Ed. East Lansing, MI: Michigan State University Press, 2017.
G. B. Biserni, S. Scarpini, A. Dondi, C. Biagi, L. Pierantoni, R. Masetti, and M. Lanari, “Potential Diagnostic and Prognostic Biomarkers for Adenovirus Respiratory Infection in Children and Young Adults,” Viruses, vol. 13, no. 9, p. 1885, Sep. 2021.
J. P. Lynch III and A. E. Kajon, “Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention,” Semin. Respir. Crit. Care Med., vol. 37, no. 4, pp. 586–602, Aug. 2016.
M. Aliyu, F. T. Zohora, A. Anka, et al., “Interleukin-6 Cytokine: An Overview of the Immune Regulation, Immune Dysregulation, and Therapeutic Approach,” Int. Immunopharmacol., vol. 111, p. 109130, Oct. 2022.
Q. Chen, J. Liu, W. Liang, Y. Chen, M. Dou, Z. Liu, et al., “Clinical Features, Replication Competence, and Innate Immune Responses of Human Adenovirus Type 7 Infection,” J. Infect. Dis., vol. 223, no. 8, pp. 1390–1399, Apr. 2021.
S. Rose-John, K. Winthrop, and L. Calabrese, “The Role of IL-6 in Host Defence Against Infections: Immunobiology and Clinical Implications,” Nat. Rev. Rheumatol., vol. 13, no. 7, pp. 399–409, Jul. 2017.
S. Khadke, N. Ahmed, N. Ahmed, et al., “Harnessing the Immune System to Overcome Cytokine Storm and Reduce Viral Load in COVID-19: A Review of the Phases of Illness and Therapeutic Agents,” Virol. J., vol. 17, no. 1, p. 154, Dec. 2020.
M. Binder, “Human Adenovirus Surveillance—United States, 2003–2016,” MMWR Morb. Mortal. Wkly. Rep., vol. 66, no. 45, pp. 1257–1262, Nov. 2017.
J. Du, X. Zhao, F. Tang, et al., “Outbreaks of Acute Respiratory Disease Associated with Human Adenovirus Infection in Closed Camps, China, December 2011–March 2014,” China CDC Wkly., vol. 3, no. 38, pp. 793–798, Sep. 2021.
L. Qi, Y. Wang, H. Wang, and J. Deng, “Adenovirus 7 Induces Interleukin-6 Expression in Human Airway Epithelial Cells via p38/NF-κB Signaling Pathway,” Front. Immunol., vol. 11, p. 551413, Sep. 2020.
J. Wei, N. Zang, J. Zhang, Y. He, H. Huang, X. Liu, et al., “Genome and Proteomic Analysis of Risk Factors for Fatal Outcome in Children with Severe Community-Acquired Pneumonia Caused by Human Adenovirus 7,” J. Med. Virol., vol. 95, no. 11, p. e29182, Nov. 2023.
R. L. Ursin and S. L. Klein, “Sex Differences in Respiratory Viral Pathogenesis and Treatments,” Annu. Rev. Virol., vol. 8, no. 1, pp. 393–414, Sep. 2021.
Y. Fu, Z. Tang, Z. Ye, et al., “Human Adenovirus Type 7 Infection Causes a More Severe Disease Than Type 3,” BMC Infect. Dis., vol. 19, no. 1, p. 919, Dec. 2019.
National Institute of Infectious Diseases, “Adenovirus and Pharyngoconjunctival Fever, 2003,” Infect. Agents Surveill. Rep., vol. 25, no. 5, pp. 94–95, 2004.
L. M. De Silva, P. Colditz, and G. Wadell, “Adenovirus Type 7 Infections in Children in New South Wales, Australia,” J. Med. Virol., vol. 29, no. 1, pp. 28–32, Sep. 1989.
D. O. Jaff, T. A. Aziz, and N. R. Smith, “The Incidence of Rotavirus and Adenovirus Infections Among Children with Diarrhea in Sulaimani Province, Iraq,” J. Biosci. Med., vol. 4, no. 1, pp. 124–131, Dec. 2015.
Q. Chen, J. Liu, W. Liang, et al., “Clinical Features, Replication Competence, and Innate Immune Responses of Human Adenovirus Type 7 Infection,” J. Infect. Dis., vol. 223, no. 8, pp. 1390–1399, Apr. 2021.